Rema A. Oliver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rema A. Oliver has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- William Robert Walsh
Surgical and Orthopedic Research Laboratories (SORL), Prince of Wales Clinical School, Faculty of Medicine, Prince of Wales Clinical School, University of New South Wales (UNSW) Sydney New South Wales Australia
15 shared publications Vedran Lovric
Surgical and Orthopaedic Research Laboratories, UNSW Sydney, Prince of Wales Clinical School, Prince of Wales Hospital, Randwick, Australia
5 shared publications- Carl Power
John E. J. Rasko and Carl Power are the authors of Flesh Made New: The unnatural history and broken promise of stem cells
3 shared publications Chris Christou
Surgical and Orthopaedic Research Laboratories, UNSW Sydney, School of Clinical Medicine, Prince of Wales Hospital, Randwick, NSW, Australia
3 shared publications- Chris Christou
Preclinical, Imaging, and Research Laboratories (PIRL), South Australian Health and Medical Research Institute (SAHMRI), Gilles Plains, Adelaide 5086, Australia
3 shared publications - John E. Pimanda
University of New South Wales
3 shared publications
Latest Publications
- 29 July 2026
- Published by SAGE Publications in The American Journal of Sports Medicine
- Vol. 54 (11) , 2732-2739
Selective Epiphysiodesis of the Anterior Distal Femoral Physis Alters Trochlear Morphology in a Rabbit Model
Background: Trochlear dysplasia is a leading contributor to patellofemoral instability, but the developmental role of the anterior distal femoral physis in shaping trochlear morphology remains poorly understood. Hypothesis: Selective closure of different portions of the anterior distal femoral physis would alter trochlear morphology in a predictable manner based on the region of growth arrest. Study Design: Controlled laboratory study. Methods: A total of 12 New Zealand White rabbits underwent unilateral selective epiphysiodesis of the anterior distal femoral physis at either the medial, central, or lateral region (n = 4 per group). Contralateral limbs served as internal controls. At 6 months postoperatively, gross, micro–computed tomography (µCT), and histological assessments were performed. µCT parameters including sulcus angle, trochlear depth, trochlear inclination, and facet symmetry were analyzed. A caliper was used to measure trochlear width as well as trochlear ridge height and length. The paired t test compared treated versus control limbs within each group. Results: Selective epiphysiodesis altered trochlear morphology in a region-specific pattern. Lateral epiphysiodesis resulted in a decreased proximal sulcus angle ( P = .005) and an increased lateral trochlear depth proximally ( P = .021), centrally ( P = .031), and distally ( P = .036), as measured on axial µCT. Central epiphysiodesis increased medial trochlear depth ( P = .009) and medial trochlear inclination ( P = .007), with greater facet symmetry ( P = .016). Medial epiphysiodesis reduced lateral trochlear depth ( P = .030) and lateral trochlear inclination ( P = .031), with an increased medial facet length ( P = .003). Direct caliper measurements showed an increased trochlear width ( P = .043) and increased medial trochlear ridge height ( P = .043) as a result of central epiphysiodesis. No cartilaginous changes were noted grossly or histologically. Conclusion: The anterior distal femoral physis significantly contributed to shaping the trochlear groove during skeletal growth. Targeted physeal closure altered trochlear morphology, supporting the potential for growth modulation strategies in managing early dysplastic changes. Lateral epiphysiodesis reduced the proximal sulcus angle and deepened the lateral groove. Central epiphysiodesis could be utilized to increase medial trochlear depth and symmetry between the medial and lateral trochlear facets. Clinical Relevance: The findings highlight the potential for early growth modulation strategies in skeletally immature patients at risk for trochlear dysplasia and patellofemoral instability. Understanding the growth contribution of the anterior distal femoral physis may inform the timing and nature of surgical or nonsurgical interventions in young patients.
- 29 July 2026
- Published by SAGE Publications in The American Journal of Sports Medicine
- Vol. 54 (11) , 2732-2739
Selective Epiphysiodesis of the Anterior Distal Femoral Physis Alters Trochlear Morphology in a Rabbit Model
Background: Trochlear dysplasia is a leading contributor to patellofemoral instability, but the developmental role of the anterior distal femoral physis in shaping trochlear morphology remains poorly understood. Hypothesis: Selective closure of different portions of the anterior distal femoral physis would alter trochlear morphology in a predictable manner based on the region of growth arrest. Study Design: Controlled laboratory study. Methods: A total of 12 New Zealand White rabbits underwent unilateral selective epiphysiodesis of the anterior distal femoral physis at either the medial, central, or lateral region (n = 4 per group). Contralateral limbs served as internal controls. At 6 months postoperatively, gross, micro–computed tomography (µCT), and histological assessments were performed. µCT parameters including sulcus angle, trochlear depth, trochlear inclination, and facet symmetry were analyzed. A caliper was used to measure trochlear width as well as trochlear ridge height and length. The paired t test compared treated versus control limbs within each group. Results: Selective epiphysiodesis altered trochlear morphology in a region-specific pattern. Lateral epiphysiodesis resulted in a decreased proximal sulcus angle ( P = .005) and an increased lateral trochlear depth proximally ( P = .021), centrally ( P = .031), and distally ( P = .036), as measured on axial µCT. Central epiphysiodesis increased medial trochlear depth ( P = .009) and medial trochlear inclination ( P = .007), with greater facet symmetry ( P = .016). Medial epiphysiodesis reduced lateral trochlear depth ( P = .030) and lateral trochlear inclination ( P = .031), with an increased medial facet length ( P = .003). Direct caliper measurements showed an increased trochlear width ( P = .043) and increased medial trochlear ridge height ( P = .043) as a result of central epiphysiodesis. No cartilaginous changes were noted grossly or histologically. Conclusion: The anterior distal femoral physis significantly contributed to shaping the trochlear groove during skeletal growth. Targeted physeal closure altered trochlear morphology, supporting the potential for growth modulation strategies in managing early dysplastic changes. Lateral epiphysiodesis reduced the proximal sulcus angle and deepened the lateral groove. Central epiphysiodesis could be utilized to increase medial trochlear depth and symmetry between the medial and lateral trochlear facets. Clinical Relevance: The findings highlight the potential for early growth modulation strategies in skeletally immature patients at risk for trochlear dysplasia and patellofemoral instability. Understanding the growth contribution of the anterior distal femoral physis may inform the timing and nature of surgical or nonsurgical interventions in young patients.
- Open Access
Chemotherapy accelerated bone ageing is reversed by NMN
Cancer patients face an array of long-term chronic diseases and accelerated biological ageing, due largely to the off-target effects of broadly cytotoxic chemotherapy drugs. This is especially a problem in children, where cancer survivors experience a subsequent high risk of bone mineral deficits and fractures, normally seen in the older population. Here, we model this to show that early-life treatment with a single dose of the commonly used chemotherapy cisplatin profoundly impairs late-life bone health, and that these bone deficits are completely resolved through treatment with the nicotinamide adenine dinucleotide (NAD + ) precursor nicotinamide mononucleotide (NMN). While we had previously shown that this same strategy protects against chemotherapy induced female infertility, this maintenance of aged bone health appears to be unrelated to endocrine changes due to protection of the ovarian reserve. Rather, this is driven by altered phosphorus homeostasis and protection against renal damage, which otherwise increases parathyroid hormone secretion to mobilise calcium stores from bone. Overall, this work highlights a new approach for maintaining healthy bone ageing in cancer survivors.
Open AccessChemotherapy accelerated bone ageing is reversed by NMN
Cancer patients face an array of long-term chronic diseases and accelerated biological ageing, due largely to the off-target effects of broadly cytotoxic chemotherapy drugs. This is especially a problem in children, where cancer survivors experience a subsequent high risk of bone mineral deficits and fractures, normally seen in the older population. Here, we model this to show that early-life treatment with a single dose of the commonly used chemotherapy cisplatin profoundly impairs late-life bone health, and that these bone deficits are completely resolved through treatment with the nicotinamide adenine dinucleotide (NAD + ) precursor nicotinamide mononucleotide (NMN). While we had previously shown that this same strategy protects against chemotherapy induced female infertility, this maintenance of aged bone health appears to be unrelated to endocrine changes due to protection of the ovarian reserve. Rather, this is driven by altered phosphorus homeostasis and protection against renal damage, which otherwise increases parathyroid hormone secretion to mobilise calcium stores from bone. Overall, this work highlights a new approach for maintaining healthy bone ageing in cancer survivors.
- Open Access
- 1 January 2024
- Published by SAGE Publications in Journal of Applied Biomaterials & Functional Materials
- Vol. 22
The influence of polyimide MP-1™ wear particles on a rodent closed fracture healing model
Joint replacements provide pain free movement for the injured or our aging population. Current prothesis mainly consist of hard metal on metal, or ceramic femoral head on ultra-high-molecular weight polyethylene (UHMWPE). In this study, a rodent fracture model was used to test the influence of wear debris from a high-performance polymer (polyimide MP-1™). Saline, MP-1™ Low Dose in Saline (1%), or MP-1 High Dose (2%) in Saline was injected directly into a standard closed unilateral femoral fracture in 12-week old Sprague Dawley rats ( n = 25) for 1, 3 and 6 weeks. Endpoints included radiography, micro-computed tomography, mechanical testing and paraffin histology. No adverse effects from the wear particles were observed from the current study based on radiology, mechanical or histological data. Although the particles were present, histological analysis revealed a progression in healing between the Polyimide treated groups and the non-treated saline control groups over the duration of 1, 3, and 6 weeks, with no inhibition from the particles. The MP-1™ wear debris generated are larger than 1 µm thus are not able to be engulfed by macrophages and cause osteolysis. This family of polymers (polyimides) may be an ideal material to consider for articulating joints and other implants in the human body.
- 1 January 2024
- Published by SAGE Publications in Journal of Applied Biomaterials & Functional Materials
- Vol. 22
Open AccessThe influence of polyimide MP-1™ wear particles on a rodent closed fracture healing model
Joint replacements provide pain free movement for the injured or our aging population. Current prothesis mainly consist of hard metal on metal, or ceramic femoral head on ultra-high-molecular weight polyethylene (UHMWPE). In this study, a rodent fracture model was used to test the influence of wear debris from a high-performance polymer (polyimide MP-1™). Saline, MP-1™ Low Dose in Saline (1%), or MP-1 High Dose (2%) in Saline was injected directly into a standard closed unilateral femoral fracture in 12-week old Sprague Dawley rats ( n = 25) for 1, 3 and 6 weeks. Endpoints included radiography, micro-computed tomography, mechanical testing and paraffin histology. No adverse effects from the wear particles were observed from the current study based on radiology, mechanical or histological data. Although the particles were present, histological analysis revealed a progression in healing between the Polyimide treated groups and the non-treated saline control groups over the duration of 1, 3, and 6 weeks, with no inhibition from the particles. The MP-1™ wear debris generated are larger than 1 µm thus are not able to be engulfed by macrophages and cause osteolysis. This family of polymers (polyimides) may be an ideal material to consider for articulating joints and other implants in the human body.
- Open Access
Physico-Chemical Characteristics and Posterolateral Fusion Performance of Biphasic Calcium Phosphate with Submicron Needle-Shaped Surface Topography Combined with a Novel Polymer Binder
A biphasic calcium phosphate with submicron needle-shaped surface topography combined with a novel polyethylene glycol/polylactic acid triblock copolymer binder (BCP-EP) was investigated in this study. This study aims to evaluate the composition, degradation mechanism and bioactivity of BCP-EP in vitro, and its in vivo performance as an autograft bone graft (ABG) extender in a rabbit Posterolateral Fusion (PLF) model. The characterization of BCP-EP and its in vitro degradation products showed that the binder hydrolyses rapidly into lactic acid, lactide oligomers and unaltered PEG (polyethylene glycol) without altering the BCP granules and their characteristic submicron needle-shaped surface topography. The bioactivity of BCP-EP after immersion in SBF revealed a progressive surface mineralization. In vivo, BCP-EP was assessed in a rabbit PLF model by radiography, manual palpation, histology and histomorphometry up to 12 weeks post-implantation. Twenty skeletally mature New Zealand (NZ) White Rabbits underwent single-level intertransverse process PLF surgery at L4/5 using (1) autologous bone graft (ABG) alone or (2) by mixing in a 1:1 ratio with BCP-EP (BCP-EP/ABG). After 3 days of implantation, histology showed the BCP granules were in direct contact with tissues and cells. After 12 weeks, material resorption and mature bone formation were observed, which resulted in solid fusion between the two transverse processes, following all assessment methods. BCP-EP/ABG showed comparable fusion rates with ABG at 12 weeks, and no graft migration or adverse reaction were noted at the implantation site nor in distant organs.
Open AccessPhysico-Chemical Characteristics and Posterolateral Fusion Performance of Biphasic Calcium Phosphate with Submicron Needle-Shaped Surface Topography Combined with a Novel Polymer Binder
A biphasic calcium phosphate with submicron needle-shaped surface topography combined with a novel polyethylene glycol/polylactic acid triblock copolymer binder (BCP-EP) was investigated in this study. This study aims to evaluate the composition, degradation mechanism and bioactivity of BCP-EP in vitro, and its in vivo performance as an autograft bone graft (ABG) extender in a rabbit Posterolateral Fusion (PLF) model. The characterization of BCP-EP and its in vitro degradation products showed that the binder hydrolyses rapidly into lactic acid, lactide oligomers and unaltered PEG (polyethylene glycol) without altering the BCP granules and their characteristic submicron needle-shaped surface topography. The bioactivity of BCP-EP after immersion in SBF revealed a progressive surface mineralization. In vivo, BCP-EP was assessed in a rabbit PLF model by radiography, manual palpation, histology and histomorphometry up to 12 weeks post-implantation. Twenty skeletally mature New Zealand (NZ) White Rabbits underwent single-level intertransverse process PLF surgery at L4/5 using (1) autologous bone graft (ABG) alone or (2) by mixing in a 1:1 ratio with BCP-EP (BCP-EP/ABG). After 3 days of implantation, histology showed the BCP granules were in direct contact with tissues and cells. After 12 weeks, material resorption and mature bone formation were observed, which resulted in solid fusion between the two transverse processes, following all assessment methods. BCP-EP/ABG showed comparable fusion rates with ABG at 12 weeks, and no graft migration or adverse reaction were noted at the implantation site nor in distant organs.
- Open Access
- 6 October 2021
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 32 (10) , 1
Author Correction: Comparative osteoconductivity of bone void fillers with antibiotics in a critical size bone defect model
- 6 October 2021
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 32 (10) , 1
Open AccessAuthor Correction: Comparative osteoconductivity of bone void fillers with antibiotics in a critical size bone defect model
- Open Access
Mesoderm-Derived PDGFRA + Cells Regulate the Emergence of Hematopoietic Stem Cells in the Dorsal Aorta
Mouse hematopoietic stem cells (HSCs) first emerge at embryonic day 10.5 (E10.5) on the ventral surface of the dorsal aorta, by endothelial-to-hematopoietic transition (EHT). We investigated whether cells with mesenchymal stem cell-like activity, which provide an essential niche for long-term HSCs (LT-HSCs) in the bone marrow, reside in the aorta- gonad-mesonephros (AGM) and contribute to the structural development of the dorsal aorta and EHT. Using transgenic mice, we demonstrate a lineage hierarchy for AGM stromal cells and traced the E10.5/E11.5 aortic endothelium and HSCs to mesoderm derived ( Mesp1 ) PDGFRA + stromal cells ( Mesp1 der PSCs). Mesp1 der PSCs dominate the sub-endothelial and ventral stroma in the E10.5–E11.5 AGM but by E13.5 were replaced by neural crest ( Wnt1 ) derived PDGFRA + stromal cells ( Wnt1 der PSCs). Co-aggregating non-hemogenic embryonic and adult endothelial cells with Mesp1 der PSCs but not with Wnt1 der PSCs resulted in activation of a hematopoietic transcriptional program in endothelial cells accompanied by EHT and generation of LT-HSCs. Dose-dependent inhibition of PDGFRA signalling or BMP, WNT, NOTCH signalling interrupted this reprogramming event. This partnership between endothelial cells and AGM Mesp1 der PSCs could potentially be harnessed to manufacture LT-HSCs from endothelium.
Open AccessMesoderm-Derived PDGFRA + Cells Regulate the Emergence of Hematopoietic Stem Cells in the Dorsal Aorta
Mouse hematopoietic stem cells (HSCs) first emerge at embryonic day 10.5 (E10.5) on the ventral surface of the dorsal aorta, by endothelial-to-hematopoietic transition (EHT). We investigated whether cells with mesenchymal stem cell-like activity, which provide an essential niche for long-term HSCs (LT-HSCs) in the bone marrow, reside in the aorta- gonad-mesonephros (AGM) and contribute to the structural development of the dorsal aorta and EHT. Using transgenic mice, we demonstrate a lineage hierarchy for AGM stromal cells and traced the E10.5/E11.5 aortic endothelium and HSCs to mesoderm derived ( Mesp1 ) PDGFRA + stromal cells ( Mesp1 der PSCs). Mesp1 der PSCs dominate the sub-endothelial and ventral stroma in the E10.5–E11.5 AGM but by E13.5 were replaced by neural crest ( Wnt1 ) derived PDGFRA + stromal cells ( Wnt1 der PSCs). Co-aggregating non-hemogenic embryonic and adult endothelial cells with Mesp1 der PSCs but not with Wnt1 der PSCs resulted in activation of a hematopoietic transcriptional program in endothelial cells accompanied by EHT and generation of LT-HSCs. Dose-dependent inhibition of PDGFRA signalling or BMP, WNT, NOTCH signalling interrupted this reprogramming event. This partnership between endothelial cells and AGM Mesp1 der PSCs could potentially be harnessed to manufacture LT-HSCs from endothelium.
- Open Access
- 15 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (3) , eabd1929
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine
Human adipocytes are a source of tissue-regenerative multipotent stem cells.
- 15 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (3) , eabd1929
Open AccessInduction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine
Human adipocytes are a source of tissue-regenerative multipotent stem cells.
- Open Access
- 25 August 2020
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 31 (9) , 1-11
Comparative osteoconductivity of bone void fillers with antibiotics in a critical size bone defect model
The study aimed to evaluate the comparative osteoconductivity of three commercially available bone void fillers containing gentamicin with respect to new bone, growth, host tissue response and resorption of the implant material. Defects were created in the cancellous bone of the distal femur and proximal tibia of 12-skeletally mature sheep and filled with three commercially available bone void fillers containing gentamicin (Stimulan-G, Cerament-G, Herafill-G). Peripheral blood was taken pre-operatively and at the time of implantation, as well as at intermittent timepoints following surgery to determine systemic gentamicin levels (5-,15- and 30- minutes, 1, 2, 3, 6, 12, 24, 48- and 72-hours, 3-, 6- and 12-weeks). Decalcified, embedded samples were stained with haematoxylin and eosin (H&E) and used to assess the host tissue response and the formation of new bone in the presence of test implant materials. No adverse reactions were noted at harvest at any time points for any cancellous implantation sites with the various implant materials. Comparative microCT analysis of the Stimulan-G, Cerament-G and Herafill-G test materials revealed a similar increase in bone surface area and volume between animals implanted with Stimulan-G or Cerament-G test materials. Animals implanted with Herafill-G test materials demonstrated the lowest increases in bone volume and surface area of the test materials tested, at levels similar to the negative control sites. By 12-weeks, Stimulan-G defects were completely closed with mature bone and bone marrow whilst the Cerament-G material was still present after 12 weeks by histological examination. In conclusion, this study demonstrated differences in the bone regenerative capacity of a range of bone void fillers in an in vivo setting.
- 25 August 2020
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 31 (9) , 1-11
Open AccessComparative osteoconductivity of bone void fillers with antibiotics in a critical size bone defect model
The study aimed to evaluate the comparative osteoconductivity of three commercially available bone void fillers containing gentamicin with respect to new bone, growth, host tissue response and resorption of the implant material. Defects were created in the cancellous bone of the distal femur and proximal tibia of 12-skeletally mature sheep and filled with three commercially available bone void fillers containing gentamicin (Stimulan-G, Cerament-G, Herafill-G). Peripheral blood was taken pre-operatively and at the time of implantation, as well as at intermittent timepoints following surgery to determine systemic gentamicin levels (5-,15- and 30- minutes, 1, 2, 3, 6, 12, 24, 48- and 72-hours, 3-, 6- and 12-weeks). Decalcified, embedded samples were stained with haematoxylin and eosin (H&E) and used to assess the host tissue response and the formation of new bone in the presence of test implant materials. No adverse reactions were noted at harvest at any time points for any cancellous implantation sites with the various implant materials. Comparative microCT analysis of the Stimulan-G, Cerament-G and Herafill-G test materials revealed a similar increase in bone surface area and volume between animals implanted with Stimulan-G or Cerament-G test materials. Animals implanted with Herafill-G test materials demonstrated the lowest increases in bone volume and surface area of the test materials tested, at levels similar to the negative control sites. By 12-weeks, Stimulan-G defects were completely closed with mature bone and bone marrow whilst the Cerament-G material was still present after 12 weeks by histological examination. In conclusion, this study demonstrated differences in the bone regenerative capacity of a range of bone void fillers in an in vivo setting.
- Open Access
Induction of Muscle Regenerative Multipotent Stem Cells from Human Adipocytes by PDGF-AB and 5-Azacytidine
Terminally differentiated murine osteocytes and adipocytes can be reprogrammed using platelet-derived growth factor–AB and 5-Azacytidine into multipotent stem cells with stromal cell characteristics. To generate a product that is amenable for therapeutic application, we have modified and optimised culture conditions to reprogram human adipocytes into induced multipotent stem cells (iMS) and expand them in vitro . The basal transcriptomes of adipocyte-derived iMS cells and matched adipose-tissue-derived mesenchymal stem cells were remarkably similar. However, there were distinct changes in histone modifications and CpG methylation at cis- regulatory regions consistent with an epigenetic landscape that was primed for tissue development and differentiation. In a non-specific tissue injury xenograft model, iMS cells contributed directly to new muscle, bone, cartilage and blood vessels with no evidence of teratogenic potential. In a cardiotoxin muscle injury model, iMS cells contributed specifically to satellite cells and myofibres without ectopic tissue formation. Taken together, human adipocyte derived iMS cells regenerate tissues in a context dependent manner without ectopic or neoplastic growth.
Open AccessInduction of Muscle Regenerative Multipotent Stem Cells from Human Adipocytes by PDGF-AB and 5-Azacytidine
Terminally differentiated murine osteocytes and adipocytes can be reprogrammed using platelet-derived growth factor–AB and 5-Azacytidine into multipotent stem cells with stromal cell characteristics. To generate a product that is amenable for therapeutic application, we have modified and optimised culture conditions to reprogram human adipocytes into induced multipotent stem cells (iMS) and expand them in vitro . The basal transcriptomes of adipocyte-derived iMS cells and matched adipose-tissue-derived mesenchymal stem cells were remarkably similar. However, there were distinct changes in histone modifications and CpG methylation at cis- regulatory regions consistent with an epigenetic landscape that was primed for tissue development and differentiation. In a non-specific tissue injury xenograft model, iMS cells contributed directly to new muscle, bone, cartilage and blood vessels with no evidence of teratogenic potential. In a cardiotoxin muscle injury model, iMS cells contributed specifically to satellite cells and myofibres without ectopic tissue formation. Taken together, human adipocyte derived iMS cells regenerate tissues in a context dependent manner without ectopic or neoplastic growth.
- 14 May 2020
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 39 (3) , 637-647
Moment arm function dictates patella sagittal height anatomy: Rabbit epiphysiodesis model alters limb length ratios and subsequent patellofemoral anatomical development
Patellofemoral anatomical dysplasia is associated with patellofemoral instability and pain. The closure of the knee physis occurs at the same age as the peak incidence of patellofemoral dislocation. This study determined the effect on the patellofemoral anatomical development in a rabbit epiphysiodesis model. Twenty‐four skeletally immature New Zealand White rabbits were divided into three groups (a) distal femur epiphysiodesis (FE) (b) proximal tibia epiphysiodesis (TE) (c) control; no epiphysiodesis (C) performed at 6 weeks of age. The primary endpoint was shape analysis using three‐dimensional reconstructions of micro‐computed tomographys (CTs) performed at 30 weeks of age. The limb length ratios (femur:tibia) were significantly different for both FE (mean 0.72, SD 0.0381, P < .001) and TE (mean 0.91, SD 0.0383, P < .001) treatment groups compared to control (mean 0.81, SD 0.0073). Patella height, as measured from the most distal point of the patella to the tibial joint surface (modified Caton‐Deschamps measurement), was lower (baja) in the FE and higher (alta) for the TE, compared with the control group. Our findings suggest femoral and tibial shortening can influence the development of the patellofemoral joint, which may be dictated by moment arm function and is potentially responsible for the etiology of patella alta. Future studies are warranted to explore this association further with the view for the development of treatment options for patella alta in human patients.
- 14 May 2020
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 39 (3) , 637-647
Moment arm function dictates patella sagittal height anatomy: Rabbit epiphysiodesis model alters limb length ratios and subsequent patellofemoral anatomical development
Patellofemoral anatomical dysplasia is associated with patellofemoral instability and pain. The closure of the knee physis occurs at the same age as the peak incidence of patellofemoral dislocation. This study determined the effect on the patellofemoral anatomical development in a rabbit epiphysiodesis model. Twenty‐four skeletally immature New Zealand White rabbits were divided into three groups (a) distal femur epiphysiodesis (FE) (b) proximal tibia epiphysiodesis (TE) (c) control; no epiphysiodesis (C) performed at 6 weeks of age. The primary endpoint was shape analysis using three‐dimensional reconstructions of micro‐computed tomographys (CTs) performed at 30 weeks of age. The limb length ratios (femur:tibia) were significantly different for both FE (mean 0.72, SD 0.0381, P < .001) and TE (mean 0.91, SD 0.0383, P < .001) treatment groups compared to control (mean 0.81, SD 0.0073). Patella height, as measured from the most distal point of the patella to the tibial joint surface (modified Caton‐Deschamps measurement), was lower (baja) in the FE and higher (alta) for the TE, compared with the control group. Our findings suggest femoral and tibial shortening can influence the development of the patellofemoral joint, which may be dictated by moment arm function and is potentially responsible for the etiology of patella alta. Future studies are warranted to explore this association further with the view for the development of treatment options for patella alta in human patients.